The Taibo? Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.
MoreRecently, we have received the Supplementary Drug Application Approval from the NMPA for Amoxicillin - Amoxicillin Capsules (0.25 g, 0.5 g) and Greats? - Irbesartan Tablets (75 mg). The products have passed the generic drug consistency evaluation, in
MoreShionogi completed the acquisition of Sumitomo Corporation’s 29% stake in C&O in December 2019. Upon completion of the acquisition, Shionogi became the sole shareholder with shareholding of 100% held in C&O.
More2019 President Shionogi Award - Fast-growing Aobo Ping
MoreFrom July 31 to August 2, the 54th National New Drug Fair was held in Shenyang International Exhibition Center......
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account 
Mobile page